Introduction/Overview Rituximab represents a cornerstone in the therapeutic application of monoclonal antibody technology, marking a significant advancement in the treatment of B-cell mediated disorders. As a chimeric murine-human monoclonal antibody, it specifically targets the CD20 antigen expressed on the surface of normal and malignant B-lymphocytes. Its introduction into clinical practice revolutionized the management of non-Hodgkin’s … Read more
Introduction/Overview Bleomycin represents a cornerstone chemotherapeutic agent within the class of antitumor antibiotics. Its unique mechanism of action, which involves direct DNA cleavage, distinguishes it from many other cytotoxic drugs that primarily target DNA synthesis or microtubule function. First isolated from Streptomyces verticillus in the 1960s, bleomycin has maintained a critical role in curative chemotherapy … Read more
Introduction/Overview Bleomycin is a cytotoxic glycopeptide antibiotic with established antineoplastic activity, primarily employed in the management of specific malignancies such as Hodgkin lymphoma, germ cell tumors, and squamous cell carcinomas. Isolated from Streptomyces verticillus, its clinical utility is distinguished by a unique mechanism of action that induces DNA strand scission and a toxicity profile notably … Read more
Introduction/Overview Paclitaxel represents a cornerstone agent in modern antineoplastic therapy, belonging to the taxane class of chemotherapeutic drugs. Originally isolated from the bark of the Pacific yew tree, Taxus brevifolia, its discovery marked a significant advancement in cancer treatment due to a novel mechanism of action distinct from other cytotoxic agents. The clinical importance of … Read more
Introduction/Overview 5-Fluorouracil (5-FU) represents a cornerstone of cytotoxic chemotherapy, belonging to the antimetabolite class of agents. Since its clinical introduction in the 1950s following the observation that rat hepatomas utilized uracil more rapidly than normal tissues, 5-FU has maintained a pivotal role in the systemic treatment of numerous solid malignancies. Its development marked a significant … Read more
Introduction/Overview Praziquantel is a broad-spectrum anthelmintic agent that represents a cornerstone in the chemotherapy of parasitic flatworm infections. Its development in the 1970s marked a significant therapeutic advance, providing an effective, well-tolerated, and single-dose oral treatment for diseases that impose substantial global morbidity. The drug’s primary clinical importance lies in its activity against trematodes of … Read more
Introduction/Overview Diethylcarbamazine (DEC) is a synthetic piperazine derivative that has served as a cornerstone anthelmintic agent for over seven decades. Its primary clinical significance lies in the treatment and control of filarial infections, which constitute a major group of neglected tropical diseases with substantial global morbidity. The drug’s introduction in the late 1940s revolutionized the … Read more
Introduction/Overview Ivermectin represents a landmark therapeutic agent in the field of antiparasitic chemotherapy. Its discovery, originating from the soil bacterium Streptomyces avermitilis, has had a profound impact on global public health, particularly in the control and elimination of neglected tropical diseases. The clinical relevance of ivermectin is underscored by its inclusion on the World Health … Read more
Introduction/Overview Ivermectin represents a landmark therapeutic agent in the field of antiparasitic chemotherapy. Its discovery, originating from the soil bacterium Streptomyces avermitilis, has had a profound impact on global public health, particularly in the control of neglected tropical diseases. The drug’s broad-spectrum activity against nematodes and arthropods, coupled with an exceptional safety profile in standard … Read more
Introduction/Overview Mebendazole represents a cornerstone agent within the benzimidazole class of anthelmintic drugs, playing a critical role in global public health initiatives against soil-transmitted helminthiases. First introduced in the early 1970s, its broad-spectrum activity against intestinal nematodes and its favorable safety profile have established it as a first-line therapeutic option and a key component of … Read more